Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Class ASSE: 603392

"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd."Announcement on Acceptance of the Clinical Trial Application for the Company's Lyophilized Recombinant Respiratory Syncytial Virus Vaccine (CHO Cells)

· Issued by Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Acceptance of the Clinical Trial Application for the Company's Lyophilized Recombinant Respiratory Syncytial Virus Vaccine (CHO Cells)

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Class A

All Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Class A news releases